Novel biological response modifiers: Phthalimides with tumor necrosis factor-α production-regulating activity

Journal of Medicinal Chemistry

Volumn 40, Issue 18, 1997, Pages 2858-2865

  Miyachi, Hiroyuki ^a   Azuma, Akihiko ^a   Ogasawara, Asuka ^a   Uchimura, Eiji ^b   Watanabe, Naoko ^b   Kobayashi, Yoshiro ^b   Kato, Fuminori ^c   Kato, Masanari ^c   Hashimoto, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c ISHIHARA SANGYO KAISHA LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,6 DIISOPROPYLPHENYL) 4,5,6,7 TETRAFLUORO 1H ISOINDOLE 1,3 DIONE; BIOLOGICAL RESPONSE MODIFIER; METHYLTHALIDOMIDE; OKADAIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PHTHALIMIDE DERIVATIVE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; DOSE RESPONSE; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LEUKEMIA CELL LINE; PROTEIN SECRETION; STRUCTURE ACTIVITY RELATION; TERATOGENICITY;

BIOLOGICAL RESPONSE MODIFIERS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HL-60 CELLS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR STRUCTURE; OKADAIC ACID; OPTICAL ROTATION; PHTHALIMIDES; STRUCTURE-ACTIVITY RELATIONSHIP; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030867908     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970109q     Document Type: Article

References (24)

1. Carswell, E. A.; Old, L. J.; Kassel, R. L.; Green, S.; Foire, N.; Williamson, B. An Endotoxin-induced Serum Factor that causes Necrosis of Tumors. Proc. Natl. Acad. Sci. U.S.A. 1975, 72, 3666-3670.
2. Siadak, K.; Sullivan, K. M. The Management of Chronic Graft-versus-Host Disease. Blood Rev. 1994, 8, 154-160.
3. Smith, C. A.; Farrah, T.; Goodwin, R. G. The TNF Receptor Superfamily of Cellular and Viral Proteins; Activation, Costimulation, and Death. Cell 1994, 76, 959-962.
4. Debs, R. J.; Fuchs, H. J.; Philip, R.; Brunette, E. N.; Duzgunes, N.; Shellito, J. E.; Kiggit, D.; Patton, J. Immunomodulatory and Toxic Effects of Free and Liposome-encapsulated Tumor Necrosis Factor in Rats. Cancer Res. 1990, 50, 375-380.
5. Boussiotis, V. A.; Nadlar, L. M.; Strominger, J. L.; Goldfield, A. E. Tumor Necrosis Factor Alpha is an Autocrine Growth Factor for Normal Human B Cells. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 7007-7011.
6. Manda, T.; Nishigaki, F.; Mori, J.; Shimomura, K. Important Role of Serotonin in the Antitumor Effects of Recombinant Human Tumor Necrosis Factor-Alpha in Mice. Cancer Res. 1988, 48, 4250-4255.
7. Komori, A.; Suganuma, M.; Okabe, S.; Zou, X.; Tius, M. A.; Fujiki, H. Canventol inhibits Tumor Promotion in CD-1 Mouse Skin through Inhibition of Tumor Necrosis Factor Alpha Release and of Protein Isoprenylation. Cancer Res. 1993, 53, 3462-3464.
8. Makonkawkeyoon, S.; Limon-Pombre, R. N. R.; Moreira, A. L.; Schauf, V.; Kaplan, G. Thalidomide inhibits the Replication of Human Immunodeficiency Virus Type 1. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 5974-5978.
9. Hotamisligil, G. S.; Spiegelman, B. H. Tumor Necrosis Factor Alpha: A Key Component of the Obesity-Diabetes Link. Diabetes 1994, 43, 1271-1278.
10. Shibata, Y.; Sasaki, K.; Hashimoto, Y.; Iwasaki, S. Tumor Necrosis Factor Alpha Production Enhancers with a Phenylphthalimide Skeleton. Biochem. Biophys. Res. Commun. 1994, 205, 1992-1997.
11. Perker, P. M.; Chao, N.; Nademanee, A.; O'Donnell, M.; Schmidt, G. M.; Snyder, D. S.; Stein, A. S.; Smith, E. P.; Molina, A.; Stepan, D. E.; Kashyap, A.; Planas, I.; Spielberger, R.; Somlo, G.; Margolin, K.; Zwingenberger, K.; Wilsman, K.; Negrin, R. S.; Long, G.; Niland, J. C.; Blume, K. G.; Forman, S. J. Thalidomide as Salvage Therapy for Chronic Graft versus Host Disease. Blood 1995, 86, 3604-3609.
12. Atra, E.; Sato, E. I. Treatment of the Cutanous Lesions of Systemic Lupus Erythematosus with Thalidomide. Clin. Exp. Rheumatol. 1993, 11, 487-493.
13. Ochonisky, S.; Verroust, J.; Bastuji-Garin, S.; Gherardi, R.; Revuz, J. Thalidomide Neuropathy Incidence and Clinicoelectrophysiologic Findings in 42 Patients. Arch. Dermatol. 1994, 730, 66-69.
14. Sampio, E. P.; Sarno, E. N.; Galilly, R.; Cohn, Z. A.; Kaplan, G. Thalidomide selectively inhibits Tumor Necrosis Factor Alpha Production by Stimulated Human Monocytes. J. Exp. Med. 1991, 173, 699-703.
15. Miyachi, H.; Azuma, A.; Hioki, E.; Iwasaki, S.; Kobayashi, Y.; Hashimoto, Y. Inducer-Specific Bidirectional Regulation by Thalidomide and Phenylphthalimides of Tumor Necrosis Factor-Alpha Production. Biochem. Biophys. Res. Commun. 1996, 224, 426-430.
16. Miyachi, H.; Azuma, A.; Hioki, E.; Iwasaki, S.; Kobayashi, Y.; Hashimoto, Y. Inducer-Specific Regulators of Tumor Necrosis Factor-Alpha Production. Chem. Pharm. Bull. 1996, 44, 1980-1982.
17. Miyachi, H.; Azuma, A.; Hioki, E.; Iwasaki, S.; Kobayashi, Y.; Hashimoto, Y. Cell Type/Inducer-Specific Bidrectional Regulation by Thalidomide and Phenylphthalimides of Tumor Necrosis Factor-alpha Production and Its Enantio-Dependence. Biochem. Biophys. Res. Commun. 1996, 226, 439-444.
18. Miyachi, H.; Azuma, A.; Hioki, E.; Iwasaki, S.; Hashimoto, Y. Enantio-Dependence of Inducer-Specific Bidirectional Regulation of Tumor Necrosis Factor (TNF)-Alpha Production: Potent TNF-Alpha Production Inhibitors. Bioorg. Med. Chem. Lett. 1996, 6, 2293-2298.
19. Ishiyama, M.; Shiga, M.; Sakamoto, K.; Mizoguchi, M.; He, D. G. A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye. Chem. Pharm. Bull. 1993, 41, 1118-1122.
20. Shibata, Y.; Sasaki, K.; Hashimoto, Y.; Iwasaki, S. Phenylphthalimides with Tumor Necrosis Factor Alpha Production-Enhancing Activity. Chem. Pharm. Bull. 1996, 44, 156-162.
21. Miyachi, H.; Azuma, A.; Hashimoto, Y. Novel Biological Response Modifiers. Yakugaku Zasshi. 1997, 117, 91-107.
22. Helm, F. C.; Frankus, E.; Friderichs, E.; Graudums, I.; Flohe, L. Comparative Teratological Investigation of Compounds structurally and pharmacologically Related to Thalidomide. Arzneim-Forsch. 1981, 31, 941-949.
23. Niwayama, S.; Benjamin, E. T.; Liu, O. J. Potent Inhibition of Tumor Necrosis Factor-alpha Production by Tetrafluorothalidomide and Tetrafluorophthalimides J. Med. Chem. 1996, 39, 3044-3045.
24. Fujihara, M.; Muroi, M.; Muroi, Y.; Ito, N.; Suzuki, T. Mechanism of Lipopolysaccharide-Triggered junB Activation in a Mouse Macrophage-like Cell Line (J774) J. Biol. Chem. 1993, 268, 14898-14905.